Sky Century Investment (SKYI) Operating Income (2024 - 2026)
Sky Century Investment (SKYI) posted quarterly Operating Income of -$4347.0 for Q2 2026, up 66.68% year-over-year from -$2608.0 in Q2 2025, and down 173.52% quarter-over-quarter from $5913.0 in Q1 2026.
Sky Century Investment (SKYI) Operating Income (2024 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has reported Operating Income for 3 consecutive years, with -$4347.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Operating Income rose 66.68% year-over-year to -$4347.0; the TTM figure through May 2026 stood at -$62452.0 (up 25.15% YoY), while the FY2025 annual figure was -$116631.0, down 59.94% from the prior year.
- Operating Income retreated to -$4347.0 in Q2 2026 per SKYI's latest filing, from $5913.0 in the prior quarter.
- Across five years, Operating Income topped out at $5913.0 in Q1 2026 and bottomed at -$41115.0 in Q4 2024.
- Historically, Operating Income has averaged -$20794.3 across 3 years, with a median of -$26406.5 in 2024.
- Annual changes were most pronounced in 2025 — Operating Income sank 1271.84% — and 2026, when it jumped 122.18%.
- Sky Century Investment's Operating Income stood at -$41115.0 in 2024, then surged by 31.38% to -$28213.0 in 2025, then soared by 84.59% to -$4347.0 in 2026.
- Business Quant data shows SKYI's Operating Income at -$4347.0 in Q2 2026, $5913.0 in Q1 2026, and -$28213.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 | -4,347.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -4,347.00 |
| Feb 28, 2026 | 5,913.00 |
| Nov 30, 2025 | -28,213.00 |
| Aug 31, 2025 | -35,805.00 |
| May 31, 2025 | -13,047.00 |
| Feb 28, 2025 | -26,664.00 |
| Nov 30, 2024 | -41,115.00 |
| Aug 31, 2024 | -2,610.00 |
| May 31, 2024 | -26,149.00 |
| Feb 29, 2024 | -35,906.00 |